Plasma S100 Calcium-Binding Protein A8/A9 and Cognitive Impairment After Acute Ischemic Stroke. | Synapse
March 12, 2026
Plasma S100 Calcium-Binding Protein A8/A9 and Cognitive Impairment After Acute Ischemic Stroke.
Key Points
This research aims to explore the relationship between plasma S100A8/A9 levels and cognitive impairment after ischemic stroke.
Measured plasma S100A8/A9 levels in patients with acute ischemic stroke
Monitored the occurrence of post-stroke cognitive impairment (PSCI)
Used statistical analysis to assess the correlation between S100A8/A9 levels and PSCI risk.
Higher baseline plasma levels of S100A8/A9 correlated with increased risk of PSCI
Identified S100A8/A9 as a potential predictive biomarker for PSCI
Abstract
Higher baseline plasma levels of S100A8/A9 were associated with an increased risk of PSCI, suggesting the potential role of S100A8/A9 as a valuable predictive biomarker for PSCI.